GRITTI, GIUSEPPE
 Distribuzione geografica
Continente #
AS - Asia 2.597
NA - Nord America 2.087
EU - Europa 1.008
SA - Sud America 401
AF - Africa 72
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 6.167
Nazione #
US - Stati Uniti d'America 1.959
SG - Singapore 750
VN - Vietnam 696
CN - Cina 446
IT - Italia 386
BR - Brasile 308
HK - Hong Kong 279
RU - Federazione Russa 151
BD - Bangladesh 103
CA - Canada 79
DE - Germania 74
SE - Svezia 69
KR - Corea 67
IN - India 64
IE - Irlanda 63
GB - Regno Unito 57
FR - Francia 54
AR - Argentina 33
ID - Indonesia 33
ZA - Sudafrica 30
UA - Ucraina 29
MX - Messico 27
TR - Turchia 26
ES - Italia 22
NL - Olanda 17
PH - Filippine 17
PK - Pakistan 17
FI - Finlandia 16
JP - Giappone 16
PL - Polonia 16
SA - Arabia Saudita 14
EC - Ecuador 13
IQ - Iraq 11
UZ - Uzbekistan 11
VE - Venezuela 11
MA - Marocco 10
AT - Austria 9
CL - Cile 8
CO - Colombia 8
KE - Kenya 8
UY - Uruguay 8
AE - Emirati Arabi Uniti 6
BE - Belgio 6
CH - Svizzera 6
DZ - Algeria 6
LB - Libano 6
PT - Portogallo 6
AZ - Azerbaigian 5
JO - Giordania 5
KZ - Kazakistan 5
MY - Malesia 5
NP - Nepal 5
PA - Panama 5
PY - Paraguay 5
EG - Egitto 4
BO - Bolivia 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
JM - Giamaica 3
LT - Lituania 3
PE - Perù 3
TN - Tunisia 3
AL - Albania 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BY - Bielorussia 2
HN - Honduras 2
IL - Israele 2
LY - Libia 2
MD - Moldavia 2
NO - Norvegia 2
RO - Romania 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AU - Australia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BS - Bahamas 1
DM - Dominica 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
MK - Macedonia 1
MU - Mauritius 1
NI - Nicaragua 1
OM - Oman 1
RE - Reunion 1
SI - Slovenia 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 6.165
Città #
Singapore 416
San Jose 273
Hong Kong 270
Ashburn 248
Ho Chi Minh City 213
Hanoi 181
Hefei 136
Milan 104
Ann Arbor 97
New York 80
Los Angeles 72
Seoul 65
The Dalles 64
Chandler 62
Dublin 60
Chicago 54
Beijing 51
Santa Clara 49
Toronto 47
Frankfurt am Main 44
Woodbridge 42
Fairfield 38
São Paulo 37
Boardman 35
Lauterbourg 35
Dallas 34
Buffalo 29
Houston 28
Wilmington 28
Rome 26
Jakarta 25
Council Bluffs 24
Da Nang 24
Haiphong 24
Moscow 20
Seattle 20
Johannesburg 18
Princeton 18
Denver 17
Jacksonville 16
Lissone 16
London 16
Quận Bình Thạnh 16
Brooklyn 15
Tokyo 15
Warsaw 15
Absecon 14
Ha Long 14
Cambridge 13
Shanghai 13
Hải Dương 12
Poplar 12
Chennai 11
Montreal 11
Tashkent 11
Atlanta 10
Biên Hòa 10
Orem 10
Stockholm 10
Thái Nguyên 10
Tianjin 10
Vũng Tàu 10
Bắc Giang 9
Dearborn 9
Jeddah 9
Mexico City 9
Brescia 8
Florence 8
Genoa 8
Lawrence 8
Manchester 8
Mumbai 8
Washington 8
Boston 7
Bắc Ninh 7
Dhaka 7
Miami 7
Montevideo 7
Munich 7
Nairobi 7
New Delhi 7
Ninh Bình 7
Nuremberg 7
Phoenix 7
Phủ Lý 7
Rio de Janeiro 7
Turin 7
Altamura 6
Barnet 6
Belo Horizonte 6
Bergamo 6
Brasília 6
Brussels 6
Can Tho 6
Curitiba 6
Guangzhou 6
Istanbul 6
Philadelphia 6
Quận Sáu 6
San Diego 6
Totale 3.666
Nome #
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 455
Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 study 347
Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation 284
Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19 251
Development of new therapeutic strategies in mature T-cell non-Hodgkin lymphomas 239
Carcik-CD19 Cells Expand In Vivo Toward a CD8+ Memory Phenotype and Their Persistence Is Associated with a Longer Duration of Response 234
Skip pattern approach toward the early access of innovative anticancer drugs 232
Low dose alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia 231
Bendamustine in combination with Ofatumumab in relapsed or refractory chronic lymphocytic leukemia: A GIMEMA Multicenter Phase II Trial 231
Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19 (Leukemia, (2021), 35, 9, (2710-2714), 10.1038/s41375-021-01299-x) 184
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 179
High inter-follicular spatial co-localization of CD8+FOXP3+ with CD4+CD8+ cells predicts favorable outcome in follicular lymphoma 178
Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19 160
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) 158
Predictive model for the risk of cytokine release syndrome with glofitamab treatment for diffuse large B-cell lymphoma 152
Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up 146
Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy 140
Chimeric antigen receptor T cells for gamma–delta T cell malignancies 137
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study 136
Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study 133
Targeting MCL-1 and BCL-2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non-Hodgkin lymphoma: Results from preclinical models and a Phase Ib study 131
Genetic and phenotypic attributes of splenic marginal zone lymphoma 131
Anti-CCR9 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemia 131
Spleen tyrosine kinase/FMS-Like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/ CB-659 128
Polatuzumab vedotin, venetoclax, and an anti-CD20 monoclonal antibody in relapsed/refractory B-cell non-Hodgkin lymphoma 124
Multidisciplinary and personalized approach to the management of mycosis fungoides with chlormethine gel: a collection of clinical experiences 122
Endothelial Injury and Thrombotic Microangiopathy in COVID-19: Treatment with the Lectin-Pathway Inhibitor Narsoplimab 117
Exposure to obinutuzumab does not affect outcomes of SARS-CoV-2 infection in vaccinated patients with newly diagnosed advanced-stage follicular lymphoma 115
Rapid immune reconstitution following the infusion of autologous, Blinatumomab Expanded T-cells (BET) in patients with B-cell indolent NHL or CLL 114
Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R-CHOP14: A SAKK 38/07 trial post-hoc analysis 114
Phase I Study of TAK-659, an Investigational, Dual SYK/FLT3 Inhibitor, in Patients with B-Cell Lymphoma A C 104
DeepMIF: Deep Learning Based Cell Profiling for Multispectral Immunofluorescence Images with Graphical User Interface 104
Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma 100
Durability of complete response after blinatumomab therapy for relapsed/refractory diffuse large B-cell lymphoma 93
SAKK38/07 study: Integration of baseline metabolic heterogeneity and metabolic tumor volume in DLBCL prognostic model 86
Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT) 83
Venetoclax-rituximab with or without bendamustine vs bendamustine-rituximab in relapsed/refractory follicular lymphoma 78
Copanlisib synergizes with conventional and targeted agents including venetoclax in B- And T-cell lymphoma models 76
Extracorporeal cytokine hemadsorption in severe COVID-19 respiratory failure 73
Immunotherapy of acute lymphoblastic leukemia and lymphoma with T cell–redirected bispecific antibodies 64
Totale 6.295
Categoria #
all - tutte 17.747
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.747


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 0 0 0 0 0 0 14
2021/2022144 9 9 11 11 15 11 6 17 3 11 15 26
2022/2023209 25 53 25 15 12 34 8 10 20 1 3 3
2023/2024167 7 2 6 13 20 34 34 6 14 6 4 21
2024/20251.012 15 42 26 19 34 121 70 52 117 189 125 202
2025/20264.373 665 445 278 511 448 190 563 156 310 340 167 300
Totale 6.295